ASSESSx Technology Ltd.
SenSore LLC is developing an objective biosensor for locating, measuring and treating pain. Biosensors are used to measure the physiological responses from the skin and fascia layers. Biosensors convert these biological responses into electrical signals displayed on mobile or PC devices. Data can now be acquired and stored. Analytics are applied for objective pain, injury, and disease treatment outcome measures.
Biosensors are moved along the skin and fascia layers to detect areas where the pain is experienced when pressure is applied. Once pain is experienced by the subject being tested, we measure the amounts of pressure applied alongside biosensor data. Subjects rate their pain experience on a scale of 1-10. We further examine the skin and fascia and collect objective bio-physiological data at a painful point(s).
The biosensor is wearable, placed on the skin, it is used to monitor the painful point(s) and responses to treatment(s). The biosensor is also able to provide a treatment method to know as Intermittent Pneumatic Compression Massage (IPCM). This massaging action reduces swelling at the painful pressure points. Inflammation is known to be the cause of pain, we measure and treat soft tissue inflammation objectively. Data, between a pain point and a non-painful point change, with treatment, over time. Pain data is collected, analytics are applied. By identifying the relationship between soft tissue inflammatory measures and subjective pain measures, over time, with sufficient data collected, we will finally have a “Window to Pain.”
According to the International Ascociation for the Study of PAin “IASP” Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Note: The inability to communicate verbally does not negate the possibility that an individual is experiencing pain and is in need of appropriate pain-relieving treatment. Pain is always subjective. Each individual learns the application of the word through experiences related to injury in early life. Biologists recognize that those stimuli which cause pain are liable to damage tissue.
The cost of Pain:
Chronic pain costs the nation up to $635 billion each year in medical treatment and lost productivity. The 2010 Patient Protection and Affordable Care Act required the Department of Health and Human Services (HHS) to enlist the IOM in examining pain as a public health problem IOM/HHS.
According to the majority of research, chronic pain affects more Americans than heart disease, cancer, and diabetes combined, making it an national epidemic. Due to increased awareness of the necessity for pain management and treatments, the world market for pain management drugs and devices is expected to grow.
Pain is considered a national health problem. It has a profound impact on the quality of life and health-associated costs for all Canadians. Statistics demonstrate that the most common reason individuals seek medical care is due to pain. The cost to health care for treating chronic pain is more than HIV, cancer, and heart disease.
Center for Disease control “CDC” say “It is essential that you and your doctor discuss treatment options, carefully considering all of the risks and benefits. Some medications, such as prescription opioids, can help relieve pain in the short term but also come with serious risks and potential complications—and should be prescribed and used carefully.”
Inflammation and Pain: The underlying cause of pain is soft tissue inflammation (manifesting as heat, pain, redness, and swelling). ystemic reviews have provided content validity; that inflmmation is the cause of most pain and many devices are already used to evaluate it. to evaluate four devices individually for their usefulness in measuring certain aspects of inflammation. The hypothesis is that a number of tools (such as algometers, galvanometers, thermography, and stethoscopes) could be used to measure aspects of inflammations independently from the skin surface.
How is pain measured: A review of current objective tools, specifically four medical devices currently used to measure aspects of inflammation for their content validity, revealed a lack of tools that adhere to evidence based practice protocols. (The Fifth Vital Sign)
Critical to measuring treatment efficacy is the ability to objectively validate and measure the existence and intensity of a patient’s pain. Clinical practitioners, such as physicians, nurses, orthopaedists, physiotherapists, chiropractors, sports medicine, multi-disciplinary rehabilitation centers, hospitals (including veterinary hospitals), involved in treating pain, are often frustrated by their inability to qualify and quantify pain, thus hindering an accurate measurement of treatment outcomes. Access to a definitive diagnostic tool with the ability to quantify or measure aspects of pain would give care providers the ability to measure the efficacy of treatment.